TherapeuticsMD (TXMD) Interest Coverage Ratio (2010 - 2026)
TherapeuticsMD (TXMD) posted Interest Coverage Ratio of 0.53 for Q1 2026, up 99.97% on a QoQ basis from 1552.0 in Q4 2025, and up 84.19% year-over-year from 0.29 in Q1 2025.
TherapeuticsMD (TXMD) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
TherapeuticsMD's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 0.53 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 84.19% year-over-year to 0.53 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.8 (up 81.67% YoY) and the FY2025 annual result came in at 3.2, down 9743.45% from the prior year.
- Interest Coverage Ratio was 0.53 for Q1 2026 at TherapeuticsMD, up from 1552.0 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 242.21 in Q4 2022 and bottomed at 1552.0 in Q4 2025.
- A 5-year average of 101.09 and a median of 3.34 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 9162.34% — and 2024, when it tumbled 944.17%.
- TherapeuticsMD's Interest Coverage Ratio stood at 242.21 in 2022, then sank by 112.89% to 31.22 in 2023, then tumbled by 944.17% to 326.0 in 2024, then slumped by 376.07% to 1552.0 in 2025, then surged by 99.97% to 0.53 in 2026.
- Business Quant data shows TXMD's Interest Coverage Ratio at 0.53 in Q1 2026, 1552.0 in Q4 2025, and 2.24 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | -0.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.53 |
| Dec 31, 2025 | -1,552.00 |
| Sep 30, 2025 | -2.24 |
| Jun 30, 2025 | -1.81 |
| Mar 31, 2025 | -3.34 |
| Dec 31, 2024 | -326.00 |
| Sep 30, 2024 | -0.52 |
| Jun 30, 2024 | -7.26 |
| Mar 31, 2024 | -0.43 |
| Dec 31, 2023 | -31.22 |
| Sep 30, 2023 | -4.05 |
| Jun 30, 2023 | -5.64 |
| Mar 31, 2023 | -6.09 |
| Dec 31, 2022 | 242.21 |
| Sep 30, 2022 | -17.49 |
| Jun 30, 2022 | -1.27 |
| Mar 31, 2022 | -0.81 |
| Dec 31, 2021 | -2.67 |
| Sep 30, 2021 | -5.31 |
| Jun 30, 2021 | -4.63 |